Taken together, these data suggest that ROCK2 supports a MYC-regulated transcriptional program in ABC-DLBCL by promoting the stability of MYC protein and that this pathway can be targeted with selective ROCK2 inhibitors. The gene discussed is ROCK2; the disease is aneurysmal bone cyst.